Developing new businesses
First written in FY2017-Q1. 5 of 9 entries say "Advanced", first in FY2020. Latest entry: 2026-05-21.
93 other companies' latest entry also says "Advanced".
- 2026-05-21AdvancedGeneral Meetings of Shareholders
「In addition to in-house development, we will continue creating new businesses through the “SHIMADZU Future Co-Creation Challenge” and the CVC “Shimadzu Future Innovation Fund.”」
The continued creation of new businesses through internal development, internal and external co-creation, and the CVC was presented. - FY2025-H1AdvancedAnnual report
「Under “Creation of New and Future Businesses,” the company is pursuing the acquisition of innovative technologies and the creation of new businesses through its corporate venture capital fund.」
Regarding the creation of new businesses, the operating details have been made concrete through the acquisition of innovative technologies and creation of new businesses via a corporate venture capital fund. - FY2024AdvancedAnnual report
「In addition to conducting R&D in the priority areas of advanced analysis, innovative biotechnology, brain and senses, and AI, the company will pursue the acquisition of innovative technologies in collaboration with startups and the creation of new businesses through the activities of the corporate venture capital fund “Shimadzu Future Innovation Fund.”」
Advanced analysis, innovative biotechnology, the five senses of the brain, and AI have been identified as priority areas for creating new businesses, and collaboration with startups through the CVC fund has also taken concrete shape. - FY2023AdvancedAnnual report
「The company aims to create new technologies and businesses by developing unique technologies and number-one solutions with customers in areas including clinical testing platforms, autonomous laboratory systems, cancer treatment support, copper processing technologies and sensory measurement systems.」
The scope of new business creation expanded to specific themes including clinical testing, autonomous experimentation, cancer treatment support, copper processing, affective measurement, and quantum and photonics technologies. - FY2020AdvancedAnnual report
「As an angiography system, we developed an AVS support system for research applications that combines analytical technology to enable efficient and rapid blood analysis.」
Concrete results are reported for the creation of new businesses through the integration of measuring and medical equipment, including the development of an AVS support system for research applications. - FY2017RestatedAnnual report
「We will pursue the creation of new businesses by leveraging the Company's strengths, including strengthening the integration of measuring instruments and medical equipment.」
The existing policy of developing new businesses has taken concrete form as the creation of new businesses through the integration of measuring instruments and medical equipment. - FY2017-Q3RestatedAnnual report
「Developing new businesses」
The policy of positioning the development of new businesses as a growth initiative remains in place. - FY2017-Q2RestatedAnnual report
「Developing new businesses」
The policy of including new businesses among the growth initiatives remains in place. - FY2017-Q1First statedAnnual report
「Developing new businesses」
First appearance of the policy to include new businesses among the growth initiatives.